<table frame="border" id="i2dfe1776-6fc4-4477-8f02-f0076ce3e07f" width="85%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<tbody>
<tr>
<td align="left" colspan="2" rowspan="1" valign="top">Drug Interactions Associated with Increased Risk of Myopathy/Rhabdomyolysis (<linkhtml href="#_fbfbd5b3-9f00-9c02-7935-420fd1e9deb5">2.6</linkhtml>, <linkhtml href="#_3c02c829-b1ac-a52a-4d21-098d3e7ff107">5.1</linkhtml>, <linkhtml href="#DRUG_INTERACTIONS">7</linkhtml>, <linkhtml href="#PHARMACOKINETICS">12.3</linkhtml>)</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Interacting Agents</paragraph>
</td>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Prescribing Recommendations</paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Cyclosporine, HIV protease inhibitors (tipranavir plus ritonavir), hepatitis C protease inhibitor (telaprevir)</paragraph>
</td>
<td align="left" colspan="1" rowspan="1" valign="bottom">Avoid atorvastatin<paragraph></paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="1" valign="top">HIV protease inhibitor (lopinavir plus ritonavir)</td>
<td align="left" colspan="1" valign="top">Use with caution and lowest dose necessary</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1" valign="top">
<paragraph>Clarithromycin, itraconazole, HIV protease inhibitors (saquinavir plus ritonavir, darunavir plus ritonavir, fosamprenavir, fosamprenavir plus ritonavir) </paragraph>
</td>
<td align="left" colspan="1" rowspan="1" valign="middle">Do not exceed 20 mg atorvastatin daily<paragraph></paragraph>
</td>
</tr>
<tr>
<td align="left" colspan="1" valign="top">HIV protease inhibitor (nelfinavir) <br/>Hepatitis C Protease inhibitor (boceprevir)</td>
<td align="left" colspan="1" valign="top">Do not exceed 40 mg atorvastatin daily</td>
</tr>
</tbody>
</table>